The OBR Video Center Features educational videos covering a wide range of oncology specific topics.
Dr. Heath, Chair, Genitourinary Oncology Multidisciplinary Team, Director, Prostate Cancer Research, Barbara Ann Karmanos Cancer Institute, Professor of Oncology, Wayne State University, explains the design and outcomes of the ACIS study evaluating the combination of apalutamide and abiraterone plus prednisone versus abiraterone plus prednisone in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC)
Tags: ASCO GU Conference CoverageProstate
Published: 13 February 2021
Kathy Oubre, MS, considers how comfortable physicians and payers are with biosimilars
Kathy Oubre, MS, Chief Executive Officer, Pontchartrain Cancer Center, considers how comfortable physicians and payers are with biosimilars
Kathy Oubre, MS, speculates on the future of biosimilars
Kathy Oubre, MS, Chief Executive Officer, Pontchartrain Cancer Center, speculates on the future of biosimilars
Kathy Oubre, MS, offers opinion on whether biosimilars are living up to their estimated cost savings
Kathy Oubre, MS, Chief Executive Officer, Pontchartrain Cancer Center, offers opinion on whether biosimilars are living up to their estimated ...
Kathy Oubre, MS, comments on the recent criticism regarding the use of biosimilars
Kathy Oubre, MS, Chief Executive Officer, Pontchartrain Cancer Center, comments on recent criticisms surrounding biosimilars
Bo Gamble, on the most important critical success factors when adopting a new payment model
Bo Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance, offers opinion on the most important critical success factors when ...
Alti Rahman, MHA\MBA, CSSBB, reflects on social determinants of health in cancer care
Alti Rahman, MHA\MBA, CSSBB, Practice Administrator, Oncology Consultants, reflects on social determinants of health and considers how an oncology practice ...
Bo Gamble, discusses the impact of consolidation on the delivery of cancer care
Bo Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance, discusses the impact of consolidation on the delivery of cancer ...
Bo Gamble, speculates on the future of alternative payment models (APMs)
Bo Gamble, Director of Strategic Practice Initiatives, Community Oncology Alliance, speculates on the future of alternative payment models (APMs) and ...
Alti Rahman, MHA\MBA, CSSBB, offers advice to oncology practices in today's cancer care landscape
Alti Rahman, MHA\MBA, CSSBB, Practice Administrator, Oncology Consultants, offers advice to oncology practices looking to succeed in today's landscape of ...
Alti Rahman, MHA\MBA, CSSBB, regarding the impact of consolidation on the delivery of cancer care
Alti Rahman, MHA\MBA, CSSBB, Practice Administrator, Oncology Consultants, regarding the impact of consolidation on the delivery of cancer care
Follow @OBRTweets